Antoine C El Khoury

Antoine C El Khoury

UNVERIFIED PROFILE

Are you Antoine C El Khoury?   Register this Author

Register author
Antoine C El Khoury

Antoine C El Khoury

Publications by authors named "Antoine C El Khoury"

Are you Antoine C El Khoury?   Register this Author

36Publications

496Reads

25Profile Views

Treatment discontinuation of long-acting injectables or oral atypical antipsychotics among Medicaid recipients with schizophrenia.

J Med Econ 2019 Nov 23;22(11):1105-1112. Epub 2019 May 23.

US Real World Value & Evidence, Janssen Pharmaceuticals, Inc , Titusville , NJ , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/13696998.2019.1615927DOI Listing
November 2019

The Predicted Long-Term Benefits of Ensuring Timely Treatment and Medication Adherence in Early Schizophrenia.

Adm Policy Ment Health 2019 Nov 19. Epub 2019 Nov 19.

RAND Corporation, 20 Park Plaza, Suite 920, Boston, MA, 02116, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10488-019-00990-7DOI Listing
November 2019

Real-World Analysis of Switching Patients with Schizophrenia from Oral Risperidone or Oral Paliperidone to Once-Monthly Paliperidone Palmitate.

Drugs Real World Outcomes 2019 Nov 30. Epub 2019 Nov 30.

Janssen Scientific Affairs, LLC., 1125 Trenton-Harbourton Road, Titusville, NJ, 08560, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40801-019-00172-9DOI Listing
November 2019

Are Medicaid Coverage Gaps Associated with Higher Health Care Resource Utilization and Costs in Patients with Schizophrenia?

Popul Health Manag 2019 Oct 8. Epub 2019 Oct 8.

Leonard Davis Institute of Health Economics and Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/pop.2019.0147DOI Listing
October 2019

Economic evaluation of paliperidone palmitate once monthly for treating chronic schizophrenia patients in the United Arab Emirates.

Curr Med Res Opin 2018 04 10;34(4):601-611. Epub 2018 Jan 10.

a Johnson & Johnson Middle East FZ LLC , Dubai , United Arab Emirates.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/03007995.2017.1417246DOI Listing
April 2018

Health-related quality of life in patients with hepatitis C virus infection in Brazil.

Rev Panam Salud Publica 2014 Mar;35(3):200-6

AllSource Professional Payrolling Service, Huntington Beach, California, United States.

View Article

Download full-text PDF

Source
March 2014

Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States.

Value Health 2013 Sep-Oct;16(6):973-86

Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA; Merck, Sharp, & Dohme Corp., Whitehouse Station, NJ, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jval.2013.07.006DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3820000PMC
November 2013

Economic evaluation of the national immunization program of rotavirus vaccination for children in Korea.

Asia Pac J Public Health 2013 Mar 10;25(2):145-58. Epub 2012 Jan 10.

Yonsei University, College of Pharmacy, Yonsei Institute of Pharmaceutical Sciences, Incheon, Korea.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1010539511416806DOI Listing
March 2013

Cost-effectiveness analysis of boceprevir for the treatment of chronic hepatitis C virus genotype 1 infection in Portugal.

Appl Health Econ Health Policy 2013 Feb;11(1):65-78

Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40258-012-0007-8DOI Listing
February 2013

The burden of hepatitis C in Europe from the patients' perspective: a survey in 5 countries.

BMC Gastroenterol 2013 Jan 17;13:16. Epub 2013 Jan 17.

Health Outcomes Practice, Kantar Health, Princeton, NJ, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-230X-13-16DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3551635PMC
January 2013

The burden of untreated hepatitis C virus infection: a US patients' perspective.

Dig Dis Sci 2012 Nov 5;57(11):2995-3003. Epub 2012 Jun 5.

Merck & Co., Inc., WP 97-A423, 770 Sumneytown Pike, West Point, PA 19486, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-012-2233-1DOI Listing
November 2012

Budget impact analysis of boceprevir and telaprevir for the treatment of hepatitis C genotype 1 infection.

Clinicoecon Outcomes Res 2012 16;4:349-59. Epub 2012 Nov 16.

Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2147/CEOR.S37205DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3503472PMC
November 2012

Burden of rotavirus gastroenteritis and distribution of rotavirus strains in Asia: a systematic review.

Vaccine 2012 Feb 31;30(7):1244-54. Epub 2011 Dec 31.

Temple University, School of Pharmacy, 3307N. Broad Street, Philadelphia, PA 19140, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.vaccine.2011.12.092DOI Listing
February 2012

Burden of rotavirus gastroenteritis in the Middle Eastern and North African pediatric population.

BMC Infect Dis 2011 Jan 7;11. Epub 2011 Jan 7.

BioMedCom Consultants inc,, 1405 TransCanada Highway, Suite 310, Montreal, Quebec H9P 2V9, Canada.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1186/1471-2334-11-9DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022719PMC
January 2011

The burden of rotavirus hospitalizations among Medicaid and non-Medicaid children younger than 5 years old.

Am J Public Health 2009 Oct;99 Suppl 2:S398-404

Global Outcomes Research, PO Box 4, WP97-243, Merck & Co, Inc, West Point, PA 19486, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2105/AJPH.2008.148494DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4504389PMC
October 2009

Drug therapy persistence and stroke recurrence.

Am J Manag Care 2006 Jun;12(6):313-9

Department of Epidemiology and Preventive Medicine, University of Maryland, 515 West Lombard St, Baltimore, MD 21201, USA.

View Article

Download full-text PDF

Source
June 2006

Developing benchmarks for adherence studies.

Expert Rev Pharmacoecon Outcomes Res 2005 Jun;5(3):229-32

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1586/14737167.5.3.229DOI Listing
June 2005